203 related articles for article (PubMed ID: 15389724)
1. The sarcolemma in the Large(myd) mouse.
Reed PW; Mathews KD; Mills KA; Bloch RJ
Muscle Nerve; 2004 Nov; 30(5):585-95. PubMed ID: 15389724
[TBL] [Abstract][Full Text] [Related]
2. Soleus muscle in glycosylation-deficient muscular dystrophy is protected from contraction-induced injury.
Gumerson JD; Kabaeva ZT; Davis CS; Faulkner JA; Michele DE
Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1430-40. PubMed ID: 20844247
[TBL] [Abstract][Full Text] [Related]
3. Extensive but coordinated reorganization of the membrane skeleton in myofibers of dystrophic (mdx) mice.
Williams MW; Bloch RJ
J Cell Biol; 1999 Mar; 144(6):1259-70. PubMed ID: 10087268
[TBL] [Abstract][Full Text] [Related]
4. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
[TBL] [Abstract][Full Text] [Related]
5. Differential distribution of dystrophin and beta-spectrin at the sarcolemma of fast twitch skeletal muscle fibers.
Williams MW; Bloch RJ
J Muscle Res Cell Motil; 1999 May; 20(4):383-93. PubMed ID: 10531619
[TBL] [Abstract][Full Text] [Related]
6. Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability.
Matsumura CY; Pertille A; Albuquerque TC; Santo Neto H; Marques MJ
Muscle Nerve; 2009 Feb; 39(2):167-76. PubMed ID: 19145649
[TBL] [Abstract][Full Text] [Related]
7. A canine minidystrophin is functional and therapeutic in mdx mice.
Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
[TBL] [Abstract][Full Text] [Related]
8. Defects in glycosylation impair satellite stem cell function and niche composition in the muscles of the dystrophic Large(myd) mouse.
Ross J; Benn A; Jonuschies J; Boldrin L; Muntoni F; Hewitt JE; Brown SC; Morgan JE
Stem Cells; 2012 Oct; 30(10):2330-41. PubMed ID: 22887880
[TBL] [Abstract][Full Text] [Related]
9. Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4.
Frigeri A; Nicchia GP; Balena R; Nico B; Svelto M
FASEB J; 2004 May; 18(7):905-7. PubMed ID: 15033928
[TBL] [Abstract][Full Text] [Related]
10. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
11. Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle - eye - brain disorders.
Holzfeind PJ; Grewal PK; Reitsamer HA; Kechvar J; Lassmann H; Hoeger H; Hewitt JE; Bittner RE
Hum Mol Genet; 2002 Oct; 11(21):2673-87. PubMed ID: 12354792
[TBL] [Abstract][Full Text] [Related]
12. Postnatal changes in sarcolemmal organization in the mdx mouse.
Reed P; Bloch RJ
Neuromuscul Disord; 2005 Aug; 15(8):552-61. PubMed ID: 16051092
[TBL] [Abstract][Full Text] [Related]
13. Transient receptor potential cation channels in normal and dystrophic mdx muscle.
Krüger J; Kunert-Keil C; Bisping F; Brinkmeier H
Neuromuscul Disord; 2008 Jun; 18(6):501-13. PubMed ID: 18504127
[TBL] [Abstract][Full Text] [Related]
14. Acute pathophysiological effects of muscle-expressed Dp71 transgene on normal and dystrophic mouse muscle.
Wieneke S; Heimann P; Leibovitz S; Nudel U; Jockusch H
J Appl Physiol (1985); 2003 Nov; 95(5):1861-6. PubMed ID: 14555666
[TBL] [Abstract][Full Text] [Related]
15. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
Yuasa K; Nakamura A; Hijikata T; Takeda S
BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
[TBL] [Abstract][Full Text] [Related]
16. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
Straub V; Rafael JA; Chamberlain JS; Campbell KP
J Cell Biol; 1997 Oct; 139(2):375-85. PubMed ID: 9334342
[TBL] [Abstract][Full Text] [Related]
17. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse.
Briguet A; Courdier-Fruh I; Foster M; Meier T; Magyar JP
Neuromuscul Disord; 2004 Oct; 14(10):675-82. PubMed ID: 15351425
[TBL] [Abstract][Full Text] [Related]
18. Plectin 1 links intermediate filaments to costameric sarcolemma through beta-synemin, alpha-dystrobrevin and actin.
Hijikata T; Nakamura A; Isokawa K; Imamura M; Yuasa K; Ishikawa R; Kohama K; Takeda S; Yorifuji H
J Cell Sci; 2008 Jun; 121(Pt 12):2062-74. PubMed ID: 18505798
[TBL] [Abstract][Full Text] [Related]
19. Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan.
Rezniczek GA; Konieczny P; Nikolic B; Reipert S; Schneller D; Abrahamsberg C; Davies KE; Winder SJ; Wiche G
J Cell Biol; 2007 Mar; 176(7):965-77. PubMed ID: 17389230
[TBL] [Abstract][Full Text] [Related]
20. Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice.
Hoyte K; Jayasinha V; Xia B; Martin PT
Am J Pathol; 2004 Feb; 164(2):711-8. PubMed ID: 14742274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
